Takeda Canada Inc. has announced two winners of the 2023 Takeda Canada Digital Health Innovation Challenge, a competition to identify and support innovative digital health solutions to improve patient outcomes and experiences.
This year’s challenge winners are two patient-led organizations with disruptive digital solutions aimed at improving the patient journey in Inflammatory Bowel Disease (IBD), the most common forms being Ulcerative Colitis and Crohn’s Disease. The two companies are IBDrelief and Ayble Health.
Ayble Health is an all-in-one virtual gastroenterology platform that helps digestive disease patients, including those with inflammatory bowel disease, find long-term relief and control over their symptoms. Ayble developed the largest GI behavioral health database in the world to build a personalized nutrition and behavioral health program for every patient, supported by a licensed coaching team. Ayble’s best-in-class outcomes are backed by 14 peer-reviewed studies developed in partnership with Northwestern University, Harvard Medical School, Mayo Clinic and Cleveland Clinic.
IBDrelief is a social enterprise that provides vital support and information to people living with IBD, their families, and the medical industry to help improve people’s quality of life. Their education platform IBDmate, allows healthcare teams to ‘prescribe’ educational videos to patients and their families prior to and after appointments. Developed in conjunction with the Cambridge University Hospital (CUH) paediatric IBD team at Addenbrooke’s Hospital, IBDmate has shown a positive impact on patients and the hospital’s IBD service through increased knowledge, accessibility, medication adherence, and trust in information.
The winners of the challenge will receive a $10,000 CAD cash prize and the opportunity to participate in Plug and Play Alberta’s Fall 2023 Accelerator Program, with the potential to further explore funding from Takeda Canada to build a proof-of-concept project. For more details and full challenge terms and conditions visit: https://takeda.info/ca-innovationchallenge.
Like this:
Like Loading...
Related
This entry was posted on September 20, 2023 at 8:06 am and is filed under Commentary with tags Takeda. You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
Patient-led Innovations in Inflammatory Bowel Disease Take the Prize in Takeda Canada’s Digital Health Challenge
Takeda Canada Inc. has announced two winners of the 2023 Takeda Canada Digital Health Innovation Challenge, a competition to identify and support innovative digital health solutions to improve patient outcomes and experiences.
This year’s challenge winners are two patient-led organizations with disruptive digital solutions aimed at improving the patient journey in Inflammatory Bowel Disease (IBD), the most common forms being Ulcerative Colitis and Crohn’s Disease. The two companies are IBDrelief and Ayble Health.
Ayble Health is an all-in-one virtual gastroenterology platform that helps digestive disease patients, including those with inflammatory bowel disease, find long-term relief and control over their symptoms. Ayble developed the largest GI behavioral health database in the world to build a personalized nutrition and behavioral health program for every patient, supported by a licensed coaching team. Ayble’s best-in-class outcomes are backed by 14 peer-reviewed studies developed in partnership with Northwestern University, Harvard Medical School, Mayo Clinic and Cleveland Clinic.
IBDrelief is a social enterprise that provides vital support and information to people living with IBD, their families, and the medical industry to help improve people’s quality of life. Their education platform IBDmate, allows healthcare teams to ‘prescribe’ educational videos to patients and their families prior to and after appointments. Developed in conjunction with the Cambridge University Hospital (CUH) paediatric IBD team at Addenbrooke’s Hospital, IBDmate has shown a positive impact on patients and the hospital’s IBD service through increased knowledge, accessibility, medication adherence, and trust in information.
The winners of the challenge will receive a $10,000 CAD cash prize and the opportunity to participate in Plug and Play Alberta’s Fall 2023 Accelerator Program, with the potential to further explore funding from Takeda Canada to build a proof-of-concept project. For more details and full challenge terms and conditions visit: https://takeda.info/ca-innovationchallenge.
Share this:
Like this:
Related
This entry was posted on September 20, 2023 at 8:06 am and is filed under Commentary with tags Takeda. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.